OrbiMed’s Owlet, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 OWLT.WS Stock Holding History

OrbiMed’s Portfolio OWLT.WS Stock Details OWLT.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-220,704	Closed	-$170K	–	155
2022 Q1	$170K	Hold	220,704	–	–	﹤0.01%	143
2021 Q4	$86K	Buy	+220,704	New	+$123K	﹤0.01%	158

Other funds holding OWLT.WS

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

ZCA

Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

OrbiMed's OWLT.WS Position: Q2 2022 in Review

OrbiMed sold out of Owlet, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (OWLT.WS) in Q2 2022, closing a stake of 220,704 shares — an estimated $170K sold.

OrbiMed first reported a position in OWLT.WS in Q4 2021 and held it in 2 quarters. The position peaked at $170K in Q1 2022. 22 funds tracked by Wall St. Rank hold OWLT.WS as of Q2 2022.

OrbiMed reported no remaining Owlet, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
OrbiMed sold 220,704 Owlet, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q2 2022, an estimated $170K.
OrbiMed first reported a position in Owlet, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q4 2021 and held it in 2 quarters.
OrbiMed's Owlet, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $170K in Q1 2022.
22 funds tracked by Wall St. Rank held Owlet, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q2 2022.

Based on OrbiMed's 13F filing for Q2 2022, filed 15 Aug 2022.